Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,501 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
Glatt S, Baeten D, Baker T, et al. · Ann Rheum Dis · 2018Clinical Trial, Phase I, Randomized Controlled Trial
- Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.
Alinaghi F, Calov M, Kristensen LE, et al. · J Am Acad Dermatol · 2019Meta-Analysis, Systematic Review
- Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
Mease PJ, Gladman DD, Merola JF, et al. · Rheumatology (Oxford) · 2024Systematic Review, Network Meta-Analysis
- Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis.
Vaengebjerg S, Skov L, Egeberg A, et al. · JAMA Dermatol · 2020Meta-Analysis, Systematic Review
- Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Wu S, Xu Y, Yang L, et al. · Front Immunol · 2023Meta-Analysis, Systematic Review
- Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.
Minozzi S, Bonovas S, Lytras T, et al. · Expert Opin Drug Saf · 2016Meta-Analysis, Systematic Review
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Mease PJ, Rahman P, Gottlieb AB, et al. · Lancet · 2020Clinical Trial, Phase III, Multicenter Study
- Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.
Gao S, Xie X, Fan L, et al. · Front Immunol · 2025Systematic Review, Network Meta-Analysis
- The Effect of a Ketogenic Diet versus Mediterranean Diet on Clinical and Biochemical Markers of Inflammation in Patients with Obesity and Psoriatic Arthritis: A Randomized Crossover Trial.
Lambadiari V, Katsimbri P, Kountouri A, et al. · Int J Mol Sci · 2024Randomized Controlled Trial
- Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study.
Mease P, van der Heijde D, Landewé R, et al. · Ann Rheum Dis · 2018Clinical Trial, Phase III, Multicenter Study
- Biomarkers in psoriatic arthritis: A meta-analysis and systematic review.
Wirth T, Balandraud N, Boyer L, et al. · Front Immunol · 2022Meta-Analysis, Systematic Review
- Psoriatic arthritis screening: a systematic review and meta-analysis.
Iragorri N, Hazlewood G, Manns B, et al. · Rheumatology (Oxford) · 2019Meta-Analysis, Research Support, Non-U.S. Gov't
- Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial.
Baraliakos X, Gossec L, Pournara E, et al. · Ann Rheum Dis · 2021Clinical Trial, Phase III, Multicenter Study
- Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis.
Montezuma T, Probst LF, Almeida MO · Adv Rheumatol · 2024Systematic Review, Network Meta-Analysis
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.
Mease PJ, Smolen JS, Behrens F, et al. · Ann Rheum Dis · 2020Comparative Study, Randomized Controlled Trial
- The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis.
Lembke S, Macfarlane GJ, Jones GT · Rheumatology (Oxford) · 2024Systematic Review, Meta-Analysis
- The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Al-Sofi RF, Bergmann MS, Nielsen CH, et al. · Int J Mol Sci · 2024Systematic Review, Meta-Analysis
- Comorbidities in psoriatic arthritis: a systematic review and meta-analysis.
Gupta S, Syrimi Z, Hughes DM, et al. · Rheumatol Int · 2021Meta-Analysis, Systematic Review
- Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
Kampylafka E, Simon D, d'Oliveira I, et al. · Arthritis Res Ther · 2019Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Vitamin D in psoriatic arthritis - A systematic review and meta-analysis.
Radik M, noga¡ H, Kolak E, et al. · Semin Arthritis Rheum · 2023Meta-Analysis, Systematic Review
- Biologic therapies and psoriatic arthritis risk in psoriasis: A systematic review and meta-analysis.
Yang L, Gao X, Wang Z, et al. · J Eur Acad Dermatol Venereol · 2026Systematic Review, Meta-Analysis
- JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis.
Campanaro F, Batticciotto A, Zaffaroni A, et al. · Autoimmun Rev · 2021Meta-Analysis, Systematic Review
- Psoriatic Arthritis and Risk of Vertebral Fracture: A Systematic Review and Meta-Analysis.
Charoenngam N, Ponvilawan B, Thongpiya J, et al. · Curr Rheumatol Rev · 2022Meta-Analysis, Systematic Review
- Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review.
Haddad A, Johnson SR, Somaily M, et al. · J Rheumatol · 2015Research Support, Non-U.S. Gov't, Systematic Review
- VEGF in psoriatic arthritis: Systematic review and meta-analysis.
Di Lorenzo B, Zoroddu S, Mangoni AA, et al. · Clin Chim Acta · 2025Systematic Review, Meta-Analysis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.